Step-wise refolding of recombinant proteins

Current Pharmaceutical Biotechnology

Volumn 11, Issue 3, 2010, Pages 285-288

  Tsumoto, Kouhei ^a   Arakawa, Tsutomu ^b   Chen, Linda ^c  

^a UNIVERSITY OF TOKYO   (Japan)

^b ALLIANCE PROTEIN LABORATORIES   (United States)

^c Life Technologies   (United States)

Author keywords

Aggregation; Antibody fragment; Arginine; Dialysis; Step wise refolding

Indexed keywords

BONE MORPHOGENETIC PROTEIN; DISULFIDE; SOLVENT;

CONCENTRATION RESPONSE; DENATURATION; DIALYSIS; PROTEIN FOLDING; REVIEW;

INCLUSION BODIES; PROTEIN DENATURATION; PROTEIN FOLDING; RECOMBINANT PROTEINS;

EID: 77950905331     PISSN: 13892010     EISSN: 18734316     Source Type: Journal    
DOI: 10.2174/138920110791111979     Document Type: Review

References (20)

1. Rudolph, R.; Lilie, H. In vitro folding of inclusion body proteins. FASEB J., 1996, 10, 49-56. (Pubitemid 26035506)
2. Clark, E. D.B. Refolding of recombinant proteins. Curr. Opin. Biotechnol., 1999, 9, 157-163.
3. Tsumoto, K.; Ejima, D.; Kumagai, I.; Arakawa, T. Practical considerations in refolding proteins from inclusion bodies. Protein Exp. Purif., 2003, 28, 1-8. (Pubitemid 36453171)
4. Clark, E.D.B.; Schwarz, E.; Rudolph, R. Inhibition of aggregation side reactions during in vitro protein folding. Methods Enzymol., 1999, 309, 217-236. (Pubitemid 29446452)
5. Chow, M.K.; Amin, A.A.; Fulton, K.F.; Whisstock, J.C.; Buckle, A.M.; Bottomley, S.P. REFOLD: an analytical database of protein refolding methods. Protein Exp. Purif., 2006, 46, 166-171.
6. Baneyx, F.; Mujacic, M. Recombinant protein folding and misfolding in Escherichia coli. Nat. Biotechnol., 2004, 22, 1399-1408.
7. Arakawa, T.; Tsumoto, K. The effects of arginine on refolding of aggregated proteins: not facilitate refolding, but suppress aggregation. Biochem. Biophys. Res. Commun., 2003, 304, 148-152. (Pubitemid 36434209)
8. Tsumoto, K.; Umetsu, M.; Kumagai, I.; Ejima, D.; Philo, J.S.; Arakawa, T. Role of arginine in protein refolding, solubilization, and purification. Biotechnol. Prog., 2004, 20, 1301-1308. (Pubitemid 39351313)
9. Arakawa, T.; Ejima, D.; Tsumoto, K.; Obeyama, N.; Tanaka, Y.; Kita, Y.; Timasheff, S.N. Suppression of protein interactions by arginine: a proposed mechanism of the arginine effects. Biophys. Chem., 2007, 127, 1-8. (Pubitemid 46304109)
10. Nakakido, M.; Kudou, M.; Arakawa, T.; Tsumoto, K. To be excluded or to bind, that is the question: Arginine effects on proteins. Curr. Pharm. Biotechnol., 2009, 10, 415-420.
11. Umetsu, M.; Tsumoto, K.; Hara, M.; Ashish, K.; Goda, S.; Adschiri, T.; Kumagai, I. How additives influence the refolding of immunoglobulin-folded proteins in a stepwise dialysis system. Spectroscopic evidence for highly efficient refolding of a single-chain Fv fragment. J. Biol. Chem., 2003, 278, 8979-8987. (Pubitemid 36800375)
12. Arai, M.; Kuwajima, K. Rapid formation of a molten globule intermediate in refolding of alpha-lactalbumin. Fold. Des., 1996, 1, 275-287. (Pubitemid 126748185)
13. Creighton, T.E.; Darby, N.J.; Kemmink, J. The roles of partly folded intermediates in protein folding. FASEB J., 1996, 10, 110-118. (Pubitemid 26035513)
14. Lin, C.C.; Chang, J.Y. Pathway of oxidative folding of bovine alpha-interferon: predominance of native disulfide-bonded folding intermediates. Biochemistry, 2007, 46, 3925-3932.
15. Chang, J.Y. Diversity of folding pathways and folding models of disulfide proteins. Antioxid. Redox Signal, 2008, 10, 171-177. (Pubitemid 350115995)
16. Tsumoto, K.; Shinoki, K.; Kondo, H.; Uchikawa, M.; Juji, T.; Kumagai, I. Highly efficient recovery of functional single-chain Fv fragments from inclusion bodies overexpressed in Escherichia coli by controlled introduction of oxidizing reagent-application to a human single-chain Fv fragment. J. Immunol. Methods, 1998, 219, 119-129. (Pubitemid 28513157)
17. Asano, R.; Kudo, T.; Makabe, K.; Tsumoto, K.; Kumagai, I. Anti-tumor activity of interleukin-21 prepared by novel refolding procedure from inclusion bodies expressed in Escherichia coli. FEBS Lett., 2002, 528, 70-76. (Pubitemid 35258002)
18. Sakamoto, S.; Caaveiro Manuel, J.M.; Sano, E.; Tanaka, Y.; Kudo, M.; Tsumoto, K. Contributions of interfacial residues of human Interleukin15 to the specificity and affinity for its private alpha-receptor. J. Mol. Biol., 2009, 389, 880-894.
19. Maeda, Y.; Koga, H.; Yamada, H.; Ueda, T.; Imoto, T. Effective renaturation of reduced lysozyme by gentle removal of urea. Protein Eng., 1995, 8, 201-205.
20. Maeda, Y.; Ueda, T.; Imoto, T. Effective renaturation of denatured and reduced immunoglobulin G in vitro without assistance of chaperone. Protein Eng., 1996, 9, 95-100. (Pubitemid 26099769)